InventisBio Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	37.29	168.79	185.53	-	-
Revenue Growth (YoY)	-77.91%	-9.02%	-	-	-
Cost of Revenue	5.02	3.92	-	-	-
Gross Profit	32.27	164.87	185.53	-	-
Selling, General & Admin	45.26	52.5	60.85	57.96	47.71
Research & Development	325.79	384.35	442.91	461.49	315.04
Other Operating Expenses	-8.71	0.09	0.12	-0	0.05
Operating Expenses	362.34	445.82	513.18	519.44	362.8
Operating Income	-330.07	-280.95	-327.65	-519.44	-362.8
Interest Expense	-	-0.66	-0.83	-1.03	-1.19
Interest & Investment Income	0.9	30.02	40.45	17.38	12.76
Currency Exchange Gain (Loss)	-	1.56	1.18	19.99	-11.33
Other Non Operating Income (Expenses)	10.05	-0.11	-0.27	-0.2	-0.21
EBT Excluding Unusual Items	-319.11	-250.14	-287.12	-483.31	-362.76
Gain (Loss) on Sale of Investments	2.49	1.3	-	-	-
Gain (Loss) on Sale of Assets	-	0.08	-	-	0
Other Unusual Items	-	8.57	3.15	-0.18	4.85
Pretax Income	-316.63	-240.2	-283.98	-483.49	-357.91
Income Tax Expense	0.24	-	-	-	-
Net Income	-316.87	-240.2	-283.98	-483.49	-357.91
Net Income to Common	-316.87	-240.2	-283.98	-483.49	-357.91
Shares Outstanding (Basic)	578	576	575	509	459
Shares Outstanding (Diluted)	578	576	575	509	459
Shares Change (YoY)	0.33%	0.26%	12.97%	10.91%	-0.25%
EPS (Basic)	-0.55	-0.42	-0.49	-0.95	-0.78
EPS (Diluted)	-0.55	-0.42	-0.49	-0.95	-0.78
Free Cash Flow	-162.36	-249.53	-314.04	-484.59	-278.59
Free Cash Flow Per Share	-0.28	-0.43	-0.55	-0.95	-0.61
Gross Margin	86.54%	97.67%	100.00%	-	-
Operating Margin	-885.14%	-166.45%	-176.61%	-	-
Profit Margin	-849.74%	-142.31%	-153.06%	-	-
Free Cash Flow Margin	-435.41%	-147.84%	-169.27%	-	-
EBITDA	-324.46	-275.49	-322.31	-514.77	-360.15
EBITDA Margin	-	-163.21%	-173.73%	-	-
D&A For EBITDA	5.6	5.47	5.34	4.68	2.64
EBIT	-330.07	-280.95	-327.65	-519.44	-362.8
EBIT Margin	-	-166.45%	-176.61%	-	-
Revenue as Reported	-	168.79	185.53	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.